Citadel Advisors »

Quoin Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Quoin Pharmaceuticals (QNRX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Quoin Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Quoin Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quoin Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $215k 33k 6.60

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Quoin Pharmaceuticals

Ikarian Capital
SummitTX Capital
Woodline Partners
Stonepine Capital Management
Millennium Management
Standard Life Aberdeen
Soleus Capital Management
Centiva Capital
Boothbay Fund Management
AIGH Capital Management
Citadel Advisors
Birchview Capital
Morgan Stanley
UBS Group
GAMMA Investing

View all funds holding Quoin Pharmaceuticals